Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Are there regulatory actions, FDA warning letters, or significant complaints against them with the Better Business Bureau or state medical boards
Off-label coverage for weight loss is uncommon
Research-grade peptides have no required purity thresholds, endotoxin testing, or independent third-party verification of label claims Bacterial endotoxins in contaminated peptides can cause fever, hypotension, and systemic inflammatory responses even at very small concentrations What it may miss It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation
No global settlement has been reached
If the FDA escalates enforcement against compounders broadly, compounded semaglutide and tirzepatide may become harder to obtain or more expensive
